共 49 条
[1]
Alhazzani W(2020)Surviving sepsis campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) Intensive Care Med 46 854-887
[2]
Møller MH(2020)COVID-19 associated pulmonary aspergillosis (CAPA)-from immunology to treatment J Fungi (Basel) 6 91-902
[3]
Arabi YM(2018)Recent advances in the pathogenesis of mucormycoses Clin Ther 40 894-2e5
[4]
Arastehfar A(2021)Mucormycosis with orbital compartment syndrome in a patient with COVID-19 Am J Emerg Med 1 264-862
[5]
Carvalho A(1997)Rhinocerebral mucormycosis: evolution of the disease and treatment options Laryngoscope 107 855-1062
[6]
van de Veerdonk FL(2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 395 1054-704
[7]
Petrikkos G(2021)Dexamethasone in hospitalized patients with COVID-19-preliminary report N Engl J Med 384 693-1399
[8]
Tsioutis C(2020)Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting [published online ahead of print, 2020 Jun 27] Clin Microbiol Infect 26 1395-666
[9]
Werthman-Ehrenreich A(2017)Mucormycosis in a diabetic patient: a case report with an insight into its pathophysiology Contemp Clin Dent 8 662-160
[10]
Peterson KL(2014)Mold infections of the central nervous system N Engl J Med 371 150-296